BioStandard Co., Ltd. participated in the Professional Beauty India 2019, one of the world's top 5 beauty fairs, and presented it’s own brands, Meline dermal filler.The fair at Bombay Exhibition Centre in Mumbai attracted more than 15,000 visitors and 500 companies.

A number of local buyers and doctors visited at BioStandard Co., Ltd.’s booth stand to have a business meeting.

They show interested in the differentiated cross-linking technology and safety management of BioStandard Co., Ltd. and trust in “made in Korea.”It brightened the prospects of entering the Indian market has the world's second largest population with 1.3 billion people.

Among all the dermal fillers on the market,Meline’s osmolality standard and pH is most similar to the human body, so it is minimized the human body’s response due to the difference in ph and osmolality between the human body and dermal fillers. Therefore, there is less pain during the procedure and after the procedure few side effects such as swelling, edema and erythema.

In particular, after the cross-linking process which is essential to make Hyaluronic acid dermal fillers lasts longer than 6~18 month inside of the human body, BioStandard Co., Ltd. execute the process of the residue of cross-linker more than six times in two weeks, while competitors do once or three times a week to remove chemical and harmful substances.

Meline is a premium product that has secured the highest safety by removing residue of cross-linker completely and lowering the endotoxin of the product to less than 10% of its competitors

Meline cross-linked Hyaluronic acid dermal filler is exported to Russia, China, Vietnam, Kazakhstan, the Middle East, the Americas, the United Kingdom, Africa, etc. Biostandard Co., Ltd. plans to accelerate its launch into Southwest Asia with the participation inthe Professional Beauty India 2019.